S. Res. 173 (119th)Bill Overview

A resolution supporting the goals and ideals of World Malaria Day.

Simple ResolutionInternational Affairs|International Affairs
Cosponsors
Support
Bipartisan
Introduced
Apr 10, 2025
Discussions
Bill Text
Current stageCommittee

Read twice and referred to the Committee on Foreign Relations.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Simple ResolutionWhat this resolution actually does

This resolution is a nonbinding statement from the Senate expressing support for World Malaria Day and U.S. leadership in fighting malaria worldwide. It highlights facts about malaria, commends past programs like the President's Malaria Initiative and the Global Fund, and urges continued efforts to reduce cases and deaths. It does not create new laws or require the executive branch to take any specific actions.

Passage rules

Simple resolutions are considered and adopted only by the chamber that introduces them (the Senate in this case) and do not go to the President. They do not have the force of law and are used to express the chamber's opinions or recognition.

A nonbinding Senate resolution supporting World Malaria Day and U.S. leadership in reducing global malaria.

It cites recent malaria statistics, commends initiatives like the President’s Malaria Initiative and the Global Fund, endorses a goal of at least 90 percent reduction in malaria incidence and mortality by 2030, welcomes new tools (vaccines, nets, diagnostics, gene drives), and encourages public-private partnerships and local ownership of programs.

Passage5/100

As a nonbinding Senate resolution it does not create law; passage in chamber likely but it does not become statute absent different legislative vehicle.

CredibilityAligned

Relative to its intended legislative type, this bill is a well‑constructed commemorative resolution: it supplies clear problem definition, supporting data, and declarative findings while remaining non‑binding and free of operational mandates.

Contention25/100

Liberals worry about equity, funding, and gene-drive safeguards.

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
Likely helpedLikely burdened

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • Potential benefitElevated U.S. leadership may strengthen diplomatic ties and influence in malaria‑endemic regions.
  • Potential benefitSupporting research and partnerships could spur U.S. biomedical R&D and related jobs and contracts.
  • Potential benefitReduced malaria incidence would likely save lives, particularly among young children and pregnant women.
Likely burdened
  • Potential burdenEndorsing gene drive research raises ecological risks and complex regulatory challenges.
  • Potential burdenThe nonbinding resolution does not appropriate funds, so practical progress depends on later appropriations.
  • Potential burdenPrioritizing malaria abroad could compete with other development or domestic public‑health funding priorities.
03 · Why people split

Why the argument around this bill splits.

Liberals worry about equity, funding, and gene-drive safeguards.
Progressive85%

Generally supportive of renewed U.S. leadership on global health, child and maternal protections, and measurable reduction goals.

Would want stronger commitments on equitable access, funding, and safeguards around new technologies.

Leans supportive
Centrist80%

Supportive of the resolution’s aims and measurable targets as pragmatic foreign-policy and public-health priorities.

Wants clarity about resources, implementation plans, and realistic timelines.

Leans supportive
Conservative75%

Likely broadly supportive of fighting malaria to protect U.S. citizens, servicemembers, and national interests, and of countering Chinese influence.

Some concern about open-ended commitments to multilateral aid and regulatory/ environmental risks from new technologies.

Leans supportive
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood5/100

As a nonbinding Senate resolution it does not create law; passage in chamber likely but it does not become statute absent different legislative vehicle.

Scope and complexity
24%
Scopenarrow
24%
Complexitylow
Why this could stall
  • Whether the House will adopt a companion or similar resolution
  • Potential pushback over explicit reference to the People’s Republic of China
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Liberals worry about equity, funding, and gene-drive safeguards.

As a nonbinding Senate resolution it does not create law; passage in chamber likely but it does not become statute absent different legisla…

Unlocked analysis

Relative to its intended legislative type, this bill is a well‑constructed commemorative resolution: it supplies clear problem definition, supporting data, and declarative findings while remaining non‑binding and free o…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis